iUFlow
iUFlow (Kesem Health Pty Ltd, Australia) sells a $99 wireless disposable home uroflowmeter and free iOS/Android bladder diary app for remote bladder monitoring, serving LUTS patients and the urologists treating them in the US and Australia.
- Company typePrivate
- Founded2015
- HeadquartersOakleigh, Australia
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What iUFlow does
iUFlow, operated by Australian private limited company Kesem Health Pty Ltd (trading as Kesem Health Corporation, founded 2015), is a connected health platform that delivers remote bladder monitoring for patients with Lower Urinary Tract Symptoms (LUTS) and the clinicians treating them. The platform combines a wireless, disposable, toilet-mounted uroflowmeter (iUFlow PRO at $99 per unit, plus an iUFlow XL variant for extended monitoring) that uses built-in sensors to capture urine volume, flow rate, and Qmax, with a free iOS/Android bladder diary app that logs voiding events, fluid intake, and bowel movements, and a cloud-based clinician dashboard (iUFlow Dashboard) for real-time remote patient review. Clinical positioning is supported by a peer-reviewed 2021 Journal of Urology study of 625 patients and analysis of 19,824 flow profiles demonstrating the diagnostic value of home uroflow versus paper bladder diaries, with the company claiming 95% measurement accuracy and approximately 90% patient compliance versus sub-10% accuracy with paper diaries.
The business runs a hybrid hardware-plus-freemium software model. The bladder diary app is free and ad-free, functioning as a top-of-funnel product-led growth lever that has accumulated over 30,000 patient users with a 4.5-star rating across 1,000+ reviews, while hardware revenue is generated through direct-to-consumer e-commerce at iuflow.com with FSA/HSA eligibility in the US. Distribution reaches both US and Australian markets with shipping handled locally, with healthcare-provider recommendations and webinar-based clinical education (featuring named adopters such as Dr. Danielle Delaney in Sydney and Dr. John C Lin in Arizona) acting as a secondary referral-driven demand channel. Apple HealthKit integration enables two-way health data interoperability for users who want consolidated records.
Commercially, iUFlow is a bootstrapped, founder-led (CEO Gil Hidas) micro-cap operation with 1 to 10 employees and only a single disclosed early-stage capital event, a 2015 seed round of approximately $253,202 led by Melbourne Angels with Geelong Angel Investor Network and Sydney Angels (with a 2018 supplementary round disclosed at $0 from Artesian VC and Brisbane Angels). There are no disclosed institutional venture rounds, enterprise payer agreements, distributor contracts, or large healthcare system anchors; customer concentration is highly dispersed across individual patients and a long tail of small urology and physical therapy practices. This structural profile, combined with reported 95% device accuracy and approximately 90% patient compliance versus sub-10% compliance with paper bladder diaries, defines both the upside thesis (validated clinical utility, large LUTS addressable market) and the key risk surface (small team, no recurring software revenue, no disclosed institutional capital beyond the 2015 seed).
iUFlow firmographics
Firmographics- Name
- iUFlow
- Legal name
- Kesem Health Pty Ltd
- Website
- https://iuflow.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- iUFlow (Kesem Health Pty Ltd, Australia) sells a $99 wireless disposable home uroflowmeter and free iOS/Android bladder diary app for remote bladder monitoring, serving LUTS patients and the urologists treating them in the US and Australia.
- Ownership category
- akta.pro rank
iUFlow industry classification
Industry- Product category
- Home Uroflowmetry Devices
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Urinalysis & Kidney Function POCT (Dipstick, Microalbumin, Creatinine) (HLAHAOAE)
- akta.pro secondary industries
- Urinalysis & Routine Screening Diagnostics (HLAHAAAG), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)
Keywords
Where iUFlow is headquartered
LocationHeadquarters
- HQ city
- Oakleigh
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
iUFlow business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Hardware Sales - iUFlow PRO: Sale of wireless, disposable uroflowmeter device. The device is priced at $99 for iUFlow PRO and includes free shipping in the US. Device warranty covers 4 weeks from unboxing or 60 urination sessions or 2 months from delivery.
- Hardware Sales - iUFlow XL: Extended-use version of the uroflowmeter for patients requiring longer monitoring periods.
- Freemium App Model: The iUFlow bladder diary app is offered free with no ads. The app can be used independently for manual voiding diary tracking, driving device adoption through product-led growth.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | iUFlow PRO device - $99 |
| Unit Pricing | Pay-as-you-go | iUFlow XL - Extended use device |
| Freemium | Monthly | iUFlow Bladder Diary App - Free |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
iUFlow product offering
Product offeringCore offering
iUFlow is a connected health platform for home bladder monitoring consisting of a wireless, disposable uroflowmeter device (iUFlow PRO and iUFlow XL) that uses built-in sensors to objectively measure urine volume, flow rate, and voiding frequency, paired with a free bladder diary mobile app on iOS and Android. Patient data syncs in real-time to a secure cloud-based iUFlow Dashboard clinician portal, enabling urologists and physical therapists to remotely diagnose and monitor Lower Urinary Tract Symptoms (LUTS) such as BPH, overactive bladder, nocturia, and urinary incontinence.
Product overview
iUFlow is a connected health platform providing remote bladder monitoring solutions. The platform consists of two core components: (1) the iUFlow Uroflow PRO or XL wireless, disposable uroflowmeter device that sits on a toilet bowl and uses sensors to measure urine volume, flow rates, and Qmax; and (2) the iUFlow Bladder Diary mobile app (free on iOS and Android) that serves as a fully automated voiding and stool diary, syncing data from the device and allowing manual logging of drinks, leaks, and urgency. A secure cloud-based iUFlow Dashboard (Clinician Portal) enables physicians and physical therapists to access real-time patient data and clinical reports for improved diagnosis and treatment of Lower Urinary Tract Symptoms (LUTS).
Differentiator
Problem solved
Functional benefit
Products and services
- iUFlow Uroflow (PRO)
Quantifiable outcome
- Patient compliance improved to ~90% for voided volumes compared to <10% with paper bladder diaries
- +3 more outcomes
Companies that use iUFlow
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
iUFlow technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability1 record
Feature4 records
iUFlow partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Google Play and Apple App StorecoreiUFlow Bladder Diary app is distributed through Google Play Store and Apple App Store, reaching millions of potential users on Android and iOS platforms.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
iUFlow competitors and assessment
Company assessmentDirect peers
- Minze Health: Belgium-based Minze Health develops at-home uroflowmetry and digital bladder monitoring solutions for urology clinics and patients, directly competing with iUFlow in the connected home uroflow category with similar hardware-plus-app-plus-clinician-portal architecture.
Emerging players
- Healthy.io: Healthy.io (with its Dip.io product) offers smartphone-based at-home urinalysis testing, overlapping with iUFlow's home urine diagnostics value proposition but focused on broader urinalysis panels (UTI, proteinuria, ACR) rather than uroflowmetry specifically.
- Withings: Withings is a connected health hardware company producing consumer-grade home health devices (scales, blood pressure monitors, sleep analyzers). They represent an emerging peer in the broader connected home health device category that could expand into urology monitoring.
- Renalytix: Renalytix is a public AI-enabled kidney diagnostics company providing early-stage kidney disease risk assessment. They are an emerging player in adjacent kidney/renal home diagnostics, with overlapping clinical customer base in nephrology and risk-monitoring business model.
- Vivante Health: Vivante Health is a digital gut health platform offering at-home GI monitoring and personalized care programs. They represent an emerging peer in the broader digital GI/urology home monitoring space with similar employer/payer go-to-market approach.
Broad incumbents
- Laborie Medical Technologies: Laborie is a large, established manufacturer of urodynamic and urology diagnostic equipment used in hospitals and clinics. As a broad incumbent in urology diagnostics, Laborie is a key competitor and potential acquirer if it moves into the home uroflow segment.
- Verathon: Verathon manufactures the BladderScan portable ultrasound product line and other urology/Airway devices. As a broader medical device incumbent with urology focus, Verathon represents a potential competitive threat or strategic acquirer in the home bladder monitoring space.
- Hollister Incorporated: Hollister is a major medical device company with a substantial continence care and urology portfolio. Their established hospital relationships and distribution scale make them a relevant incumbent competitor and potential partner in the urology home monitoring category.
- Coloplast: Coloplast is a global leader in ostomy, continence, and urology care products. Their direct relationships with urology patients and continence specialists make them a strategic comparable for patient-facing urology home monitoring solutions.
- Becton Dickinson (BD): BD is a global medical technology giant with a significant urology and surgical solutions portfolio. As a broad incumbent, BD represents both a competitive threat and a potential strategic acquirer in the home urology diagnostics space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
iUFlow social profiles
Digital presenceiUFlow financial estimates
Financial estimateRevenue estimate
Valuation estimate
iUFlow leadership team
Management profileNumber of profiles
Profiles1 record
iUFlow funding detail
Funding detailFunding overview
Funding rounds2 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
iUFlow M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about iUFlow
What does iUFlow do?
iUFlow is a connected health platform for home bladder monitoring consisting of a wireless, disposable uroflowmeter device (iUFlow PRO and iUFlow XL) that uses built-in sensors to objectively measure urine volume, flow rate, and voiding frequency, paired with a free bladder diary mobile app on iOS and Android. Patient data syncs in real-time to a secure cloud-based iUFlow Dashboard clinician portal, enabling urologists and physical therapists to remotely diagnose and monitor Lower Urinary Tract Symptoms (LUTS) such as BPH, overactive bladder, nocturia, and urinary incontinence.
Is iUFlow a public or private company?
iUFlow is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was iUFlow founded?
iUFlow was founded in 2015. It employs 1 to 10 people.
Where is iUFlow based?
iUFlow is headquartered in Oakleigh, Australia, in the Oceania region.
How does iUFlow make money?
Three revenue lines are on record. Hardware Sales - iUFlow PRO is the primary driver. The others are hardware Sales - iUFlow XL and freemium App Model.
Who are iUFlow's main competitors?
Minze Health is listed as a direct peer. Emerging players are Healthy.io, Withings, Renalytix and Vivante Health. Broad incumbents are Laborie Medical Technologies, Verathon, Hollister Incorporated, Coloplast and Becton Dickinson (BD).
Does iUFlow have an API?
No public API is recorded for iUFlow.
What industry is iUFlow in?
iUFlow's product category is Home Uroflowmetry Devices. Its primary akta.pro industry code is HLAHAOAE, Urinalysis & Kidney Function POCT (Dipstick, Microalbumin, Creatinine), with a secondary code of HLAHAAAG, Urinalysis & Routine Screening Diagnostics. Its NAICS code is 62151 and its SIC code is 2835.